Rigaku to Lead Development of New Soft X-ray Phase-Based Microscope for Biomedical Applications
THE WOODLANDS, Texas, Oct. 6, 2020 /PRNewswire-PRWeb/ -- Rigaku Corporation , a global leader in X-ray analytical instrumentation, will lead a consortium of scientific and academic research institutions in the development a new soft X-ray phase-based microscope for biomedical applications.
- THE WOODLANDS, Texas, Oct. 6, 2020 /PRNewswire-PRWeb/ -- Rigaku Corporation , a global leader in X-ray analytical instrumentation, will lead a consortium of scientific and academic research institutions in the development a new soft X-ray phase-based microscope for biomedical applications.
- Rigaku, University College London, Creatv MicroTech, Argonne National Laboratory and Sloan Kettering Institute for Cancer Research have been granted funds by the National Institute of Biomedical Imaging and Bioengineering ( NIBIB ) to develop an intensity-modulated phase-based soft X-ray microscope.
- X-rays can penetrate thick tissue, but X-ray microscope imaging systems that are available commercially are not optimal for soft tissue imaging.
- Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.